Suchen
Addex Therapeutics Ltd
ADXNZur Watchlist hinzufügen
5.790USD
+0.120+2.10%
Handelsschluss 07/02, 13:00（ET）Kurse um 15 Minuten verzögert
5.76MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Addex Therapeutics Ltd Unternehmen
Addex Therapeutics Ltd is a Switzerland-based clinical-stage pharmaceutical company. The Company focuses on development and commercialization of orally available small molecule drugs known as allosteric modulators for neurological disorders. The Company’s clinical programs pipeline include dipraglurant (mGlu5 NAM), which is Phase 2a placebo-controlled clinical trial for Parkinson's disease levodopa-induced dyskinesia (PD-LID), and is being prepared to enter registration trials for PD-LID, and ADX71149 (mGlu2 positive allosteric modulator or PAM), which is being developed in collaboration by its partner Janssen Pharmaceuticals, Inc to treat schizophrenia and anxious depression. It also is advancing several preclinical programs, including GABABPAM for pain, overactive bladder and other disorders, mGlu7 NAM for post-traumatic stress disorder, mGlu2 NAM for mild neurocognitive disorders, mGlu4 PAM for Parkinson’s disease and mGlu3 PAM for neurodegenerative disorders.
Addex Therapeutics Ltd Informationen
BörsenkürzelADXN
Name des UnternehmensAddex Therapeutics Ltd
IPO-datumMay 22, 2007
CEODyer (Tim)
Anzahl der mitarbeiter2
WertpapierartDepository Receipt
GeschäftsjahresendeMay 22
AddresseChemin des Mines, 9
StadtPLAN-LES-OUATES
BörseNASDAQ OMX - NASDAQ BASIC
LandSwitzerland
Postleitzahl1202
Telefon41228841555
Websitehttps://www.addextherapeutics.com/en/
BörsenkürzelADXN
IPO-datumMay 22, 2007
CEODyer (Tim)
Führungskräfte von Addex Therapeutics Ltd
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Tim Dyer
Mr. Tim Dyer
Chief Executive Officer, Co-Founder, Member of the Executive Management, Director
Chief Executive Officer, Co-Founder, Member of the Executive Management, Director
--
--
Dr. Raymond G. (Ray) Hill
Dr. Raymond G. (Ray) Hill
Non-Executive Independent Member of the Board of Directors
Non-Executive Independent Member of the Board of Directors
--
--
Dr. Vincent Lawton
Dr. Vincent Lawton
Independent Non-Executive Chairman of the Board of Directors
Independent Non-Executive Chairman of the Board of Directors
--
--
Dr. Roger G. Mills
Dr. Roger G. Mills
Member of the Executive Management, Chief Medical Officer, Member of the Board of Directors
Member of the Executive Management, Chief Medical Officer, Member of the Board of Directors
--
--
Mr. Jake R. Nunn
Mr. Jake R. Nunn
Non-Executive Independent Member of the Board of Directors
Non-Executive Independent Member of the Board of Directors
--
--
Dr. Isaac Manke
Dr. Isaac Manke
Non-Executive Independent Member of the Board of Directors
Non-Executive Independent Member of the Board of Directors
--
--
Dr. Mikhail Kalinichev
Dr. Mikhail Kalinichev
Member of the Executive Management, Head of Translational Science
Member of the Executive Management, Head of Translational Science
--
--
Mr. Lenaic Teyssedou
Mr. Lenaic Teyssedou
Member of the Executive Management, Head of Finance
Member of the Executive Management, Head of Finance
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Tim Dyer
Mr. Tim Dyer
Chief Executive Officer, Co-Founder, Member of the Executive Management, Director
Chief Executive Officer, Co-Founder, Member of the Executive Management, Director
--
--
Dr. Raymond G. (Ray) Hill
Dr. Raymond G. (Ray) Hill
Non-Executive Independent Member of the Board of Directors
Non-Executive Independent Member of the Board of Directors
--
--
Dr. Vincent Lawton
Dr. Vincent Lawton
Independent Non-Executive Chairman of the Board of Directors
Independent Non-Executive Chairman of the Board of Directors
--
--
Dr. Roger G. Mills
Dr. Roger G. Mills
Member of the Executive Management, Chief Medical Officer, Member of the Board of Directors
Member of the Executive Management, Chief Medical Officer, Member of the Board of Directors
--
--
Mr. Jake R. Nunn
Mr. Jake R. Nunn
Non-Executive Independent Member of the Board of Directors
Non-Executive Independent Member of the Board of Directors
--
--
Dr. Isaac Manke
Dr. Isaac Manke
Non-Executive Independent Member of the Board of Directors
Non-Executive Independent Member of the Board of Directors
--
--
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Addex Therapeutics Ltd?
Die fünf größten Anteilseigner von Addex Therapeutics Ltd sind: Mr. Tim Dyer
Wie viele Institutionen halten Anteile an Addex Therapeutics Ltd (ADXN)?
Mit Stand vom 2026Q1 halten 8 Institutionen Anteile an Addex Therapeutics Ltd, mit einem Gesamtmarktwert von etwa 454.00, was 0.05% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -12676.00 gestiegen.